Citations

Showing 10 of 108083 citations.

Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study
Hartwig, Matthew G. , Abbas, Abbas E. , Dylewski, Mark, Fabian, Thomas , Jett, Kimble, Meyers, Bryan , Reddy, Rishindra M. , Rice, David C. , Ross, Patrick, Sarkaria, Inderpal S., Schumacher, Lana , Spier, Lawrence N., Tisol, William B., Wigle, Dennis A. , Zervos, Michael , Herrera, Luis Javier Pentón , Kent, Michael Sean , Cerfolio, Robert J. , Herrera, Luis J., Lazzaro, Richard S. , Reed, Michael F.

Mayo Clinic

Annals of Surgery | February 10, 2023 | Volume: 277 | Issue: 6 | Pages: 1002-1009

10.1097/sla.0000000000005820 | PMID 36762564 Get It

Objective: The aim of this study was to analyze overall survival (OS) of robotic-assisted lobectomy (RL), video-assisted thoracoscopic lobectomy (VATS), and open lobectomy (OL) performed by experienced thoracic surgeons across multiple institutions. Summary Background Data: Surgeons have increasingly adopted RL for resection of early-stage lung cancer. Comparative survival data following these approaches is largely from single-institution case series or administrative data sets. Methods: Retrospective data was collected from 21 institutions from 2013 to 2019. Consecutive cases performed for clinical stage IA–IIIA lung cancer were included. Induction therapy patients were excluded. The propensity-score method of inverse-probability of treatment weighting was used to balance baseline characteristics. OS was estimated using the Kaplan-Meier method. Multivariable Cox proportional hazard models were used to evaluate association among OS and relevant risk factors. Results: A total of 2789 RL, 2661 VATS, and 1196 OL cases were included. The unadjusted 5-year OS rate was highest for OL (84%) followed by RL (81%) and VATS (74%); P=0.008. Similar trends were also observed after inverse-probability of treatment weighting adjustment (RL 81%; VATS 73%, OL 85%, P=0.001). Multivariable Cox regression analyses revealed that OL and RL were associated with significantly higher OS compared with VATS (OL vs. VATS: hazard ratio=0.64, P<0.001 and RL vs. VATS: hazard ratio=0.79; P=0.007). Conclusions: Our finding from this large multicenter study suggests that patients undergoing RL and OL have statistically similar OS, while the VATS group was associated with shorter OS. Further studies with longer follow-up are necessary to help evaluate these observations.
Arthroscopic-Assisted Anterior Glenoid Reconstruction Using Nonrigid Fixation With Distal Tibia Osteochondral Allograft
Riccio, Cory A., Tokish, John M. , Kilcoyne, Kelly G. , Hoyt, Benjamin W , LeClere, Lance E. , Dickens, Jonathan F.

Mayo Clinic

Video Journal of Sports Medicine | February 10, 2023 | Volume: 3 | Issue: 1 | Pages: No page available

10.1177/26350254221131053 | PMID 40308546 Get It

Introduction: Traumatic anterior glenohumeral instability events result in a capsulolabral (Bankart lesion) and/or osseous injury with subsequent attritional bone loss, particularly with recurrence. Up to 88% of patients with recurrent instability experience glenoid bone loss, which predisposes to future dislocations and subluxations, even with arthroscopic capsulolabral repair. The surgical management of glenoid bone loss includes a number of different techniques such as the Latarjet or coracoid transfer as well as other osseous and osteoarticular autografts and allografts. However, operative management of shoulder instability has increasingly shifted toward arthroscopic approaches with preservation of anatomy when possible. Indications: Arthroscopic-assisted allograft distal tibia bone block augmentation to the anterior glenoid is indicated for revision anterior glenohumeral instability procedures with anterior bone loss and in primary cases of anterior instability with critical bone loss. Technique: Our technique for nonrigid arthroscopic anterior glenoid reconstruction with allograft distal tibia and anterior labral repair is performed preferentially in the lateral position without necessitating patient repositioning. The preplanned tibial bone block is prepared on a back table prior to the arthroscopic procedure. After creation of portals and elevation of labral tissue, a guide and drill are used to introduce a retrograde reamer which is deployed to create a perpendicular edge for apposition of the allograft tibia. The bone block is then introduced through a rotator interval portal by pulling sutures retrograde through glenoid bone tunnels and is secured to the prepared surface medial to the liberated labrum. The articular surface of the graft and glenoid are aligned and suture-based fixation is used to compress the bone block against the native glenoid. The anterior labral tissue is then mobilized over the graft and repaired to the native glenoid when possible. Description/Conclusion: The benefits of allograft tibia augmentation for anterior instability with glenoid bone loss include an anatomic joint surface restoration including articular cartilage, lack of donor site morbidity, and a minimally invasive arthroscopic approach. When performed arthroscopically and with nonrigid fixation, this technique permits concurrent anterior labral repair and anatomic reconstruction, safe graft passage without necessity of a far medial portal, and expeditious return to function.
High-sensitivity Troponin I Predicts Major Cardiovascular Events after Non-Cardiac Surgery: A Vascular Events in Non-Cardiac Surgery Patients Cohort Evaluation (VISION) Substudy
Borges, Flávia K. , Duceppe, Emmanuelle , Heels‐Ansdell, Diane , Tandon, Vikas , Pearse, Rupert M. , Srinathan, Sadeesh, Garg, Amit X. , Sapsford, Robert J., Marcucci, Maura , Kavsak, Peter A. , Pettit, Shirley , McGillion, Michael , Conen, David , Thomas, Sabu , Mueller, Christian, Jaffe, Allan S. , Whitlock, Richard , Mueller, Christian , Jaffe, Allan S. , Borges, Flavia , Patel, Ameen , Sessler, Daniel I. , Chan, Matthew T.V. , Ofori, Sandra , Spence, Jessica , Belley‐Côté, Emilie P. , Whitlock, Richard , Lamy, Andre L. , Devereaux, P.J.

Mayo Clinic

Clinical Chemistry | February 10, 2023 | Volume: 69 | Issue: 5 | Pages: 492-499

10.1093/clinchem/hvad005 | PMID 36762424 Get It

Abstract Background Myocardial injury after non-cardiac surgery (MINS), based on measurement of troponin T, is associated with perioperative major adverse cardiovascular events (MACE). We therefore determined the high-sensitivity troponin I (hsTnI) thresholds associated with 30 day MACE after non-cardiac surgery. Methods We performed a nested biobank cohort study of 4553 patients from the Vascular Events in Non-Cardiac Surgery Patients Cohort Evaluation (VISION) Study. We measured hsTnI (ADVIA Centaur® hsTnI assay) on postoperative days 1 to 3 in patients ≥45 years undergoing non-cardiac surgery. An iterative Cox proportional hazard model determined peak postoperative hsTnI thresholds independently associated with MACE (i.e., death, myocardial infarction occurring on postoperative day 4 or after, non-fatal cardiac arrest, or congestive heart failure) within 30 days after surgery. Results MACE occurred in 89/4545 (2.0%) patients. Peak hsTnI values of &lt;75 ng/L, 75 ng/L to &lt;1000 ng/L, and ≥1000 ng/L were associated with 1.2% (95% CI, 0.9–1.6), 7.1% (95% CI, 4.8–10.5), and 25.9% (95% CI, 16.3–38.4) MACE, respectively. Compared to peak hsTnI &lt;75 ng/L, values 75 ng/L to &lt;1000 ng/L and ≥1000 ng/L were associated with adjusted hazard ratios (aHR) of 4.53 (95% CI, 2.75–7.48) and 16.17 (95% CI, 8.70–30.07), respectively. MACE was observed in 9% of patients with peak hsTnI ≥75 ng/L vs 1% in patients with peak hsTnI &lt;75 ng/L (aHR 5.76; 95% CI, 3.64–9.11). A peak hsTnI ≥75 ng/L was associated with MACE in the presence (aHR 9.35; 95% CI, 5.28–16.55) or absence (aHR 3.99; 95% CI, 2.19–7.25) of ischemic features of myocardial injury. Conclusion A peak postoperative hsTnI ≥75 ng/L was associated with &gt;5-fold increase in the risk of 30 days MACE compared to levels &lt;75 ng/L. This threshold could be used for MINS diagnosis when the ADVIA Centaur hsTnI assay is used. Clinicaltrials.gov Registration Number: NCT00512109.
Radiomics analysis in medical imaging research
Elmahdy, Mahmoud , Sebro, Ronnie

Mayo Clinic

Journal of Medical Radiation Sciences | February 10, 2023 | Volume: 70 | Issue: 1 | Pages: 3-7

10.1002/jmrs.662 | PMID 36762402 Get It

Emerging approaches in neurostimulation for epilepsy
Osman, Gamaleldin , Starnes, Keith , Gregg, Nicholas M. , Osman, Gamaleldin M, Gregg, Nicholas M , Starnes, Donnie Keith , Lundstrom, Brian N. , Simpson, Hugh D.

Mayo Clinic

Current Opinion in Neurology | February 10, 2023 | Volume: 36 | Issue: 2 | Pages: 69-76

10.1097/wco.0000000000001138 | PMID 36762660 Get It

Purpose of review Neurostimulation is a quickly growing treatment approach for epilepsy patients. We summarize recent approaches to provide a perspective on the future of neurostimulation. Recent findings Invasive stimulation for treatment of focal epilepsy includes vagus nerve stimulation, responsive neurostimulation of the cortex and deep brain stimulation of the anterior nucleus of the thalamus. A wide range of other targets have been considered, including centromedian, central lateral and pulvinar thalamic nuclei; medial septum, nucleus accumbens, subthalamic nucleus, cerebellum, fornicodorsocommissure and piriform cortex. Stimulation for generalized onset seizures and mixed epilepsies as well as increased efforts focusing on paediatric populations have emerged. Hardware with more permanently implanted lead options and sensing capabilities is emerging. A wider variety of programming approaches than typically used may improve patient outcomes. Finally, noninvasive brain stimulation with its favourable risk profile offers the potential to treat increasingly diverse epilepsy patients. Summary Neurostimulation for the treatment of epilepsy is surprisingly varied. Flexibility and reversibility of neurostimulation allows for rapid innovation. There remains a continued need for excitability biomarkers to guide treatment and innovation. Neurostimulation, a part of bioelectronic medicine, offers distinctive benefits as well as unique challenges.
Plasticity of the adult circle of Willis in response to flow diversion stents
Tatit, Rafael Trindade , Ogilvy, Christopher S. , Yasuda, Thomas A., Baccin, Carlos E. , Tatit, Rafael T , Ogilvy, Christopher S , Shutran, Max S. , Tawk, Rabih G. , Yasuda, Thomas Alexandre

Mayo Clinic

Surgical Neurology International | February 10, 2023 | Volume: 14 | Issue: No issue available | Pages: 49

10.25259/sni_1139_2022 | PMID 36895205 Get It

Background: We present five patients with remodeling of the adult circle of Willis in response to flow diverter stents (FDSs) at the anterior communicating artery (AComA) and the posterior communicating artery (PComA). The observed changes provide a paradigm of how flow change can institute anatomic changes in the adult circle of Willis vasculature. Case Description: In the first two cases, after placement of the FDS covering the AComA, there was an increase in size and flow of the contralateral A1-anterior cerebral artery which had previously been hypoplastic. In one of the cases, this led to the filling of the aneurysm and required placement of coils within the lesion which was curative. In case three, the FDS effect led to asymptomatic occlusion of the PComA and associated aneurysm without change of the ipsilateral P1-segement of posterior-cerebral-artery (P1-PCA) caliber. In the fourth case, the FDS covering an aneurysm with a fetal PCA arising from its neck resulted in significant reduction of the aneurysm size, persistent flow and caliber of the fetal PCA, and the hypoplastic ipsilateral P1-PCA. Finally, in the fifth case, after FDS occlusion of the PComA and aneurysm there was increasement in diameter of the ipsilateral P1-PCA that was previously hypoplastic. Conclusion: The use of FDS can affect vessels covered by the device and other arteries of the circle of Willis adjacent to the FDS. The phenomena illustrated in the hypoplastic branches appear to be a compensatory response to the hemodynamic changes induced by the divertor and to the altered flow in the circle of Willis.
Relationship Between Premature Birth and Acquired Heart Disease in Adulthood: A Meta-analysis and Systematic Review
Mongkonsritragoon, Wimwipa , Tokavanich, Nithi , Cheungpasitporn, Wisit , Chiengthong, Kanhatai , Cheungpasitporn, Wisit , Prasitlumkum, Narut , Chokesuwattanaskul, Ronpichai

Mayo Clinic

Journal of Neonatology | February 10, 2023 | Volume: 37 | Issue: 1 | Pages: 24-30

10.1177/09732179231151754 Get It

Introduction Premature birth has a causal relationship with hypertension and diabetes, which are significant risk factors for major cardiovascular disease. Nonetheless, little is known whether premature birth portends future risks of acquired heart diseases, for example, ischemic heart disease (IHD), heart failure (HF), and valvular heart disease (VHD). Methods We comprehensively searched the databases of MEDLINE, EMBASE, and Cochrane database from inception to December 2021. Studies with prospective and retrospective cohort designs that reported the association between premature birth and acquired heart disease, including IHD, HF, and VHD, were included. Data from each study were combined with a random-effects model. The results were reported in the hazard ratio (HR) with 95% confidence intervals. Results The selected studies were comprised of 7 studies, with 5 studies involving premature birth and the development of IHD in adulthood and 2 studies involving premature birth and HF. No studies reporting the relationship between premature birth and VHD met our initial inclusion criteria. Our study did not find any association between premature birth and IHD in the adulthood (HR 1.14 95% CI 0.91-1.19, P = .16, I 2 = 51%). We found the association between premature birth and acquired HF (HR 1.53 95% CI 1.08-2.16, P = .01, I 2 = 0) Conclusion Premature birth was not statistically associated with IHD in adulthood, but there was a significant association between preterm and HF.
Correlation between “Snake-Eyes” Sign and Role of Surgery with a Focus on Postoperative Outcome: A Systematic Review
Scalia, Gianluca , Costanzo, Roberta , Brunasso, Lara , Garufi, Giada , Bonosi, Lapo , Ricciardo, Giuseppe, Maugeri, Rosario , Umana, Giuseppe Emmanuele , Umana, Giuseppe Emmanuele , Graziano, Francesca , Nicoletti, Giovanni Federico , Cardali, Salvatore Massimiliano , Iacopino, Domenico Gerardo

Mayo Clinic

Brain Sciences | February 10, 2023 | Volume: 13 | Issue: 2 | Pages: 301

10.3390/brainsci13020301 | PMID 36831844 Get It

(1) Background: The “snake-eyes” sign represents a unique finding characterized by bilateral hyperintense symmetric, circular, or ovoid foci on T2-weighted MRI sequences in the anterior horn cells of the spinal cord. There are conflicting opinions as some authors affirm that it does not affect the prognosis of cervical myelopathy while other papers emphasize the opposite, stating how the “snake-eyes” sign constitutes an irreversible lesion and a predictor of poor prognosis. This systematic review evaluates the correlation between the “snake-eyes” sign and the prognosis of cervical myelopathy after surgery including anterior and/or posterior approaches; (2) Methods: A systematic literature review was conducted following the PRISMA statement and a total of seven papers were included; (3) Results: A total of 419 patients were evaluated, with a mean age of 55.72 ± 14.38 years. After surgery, 26.01% of patients experienced a significant clinical improvement, while in 61.81%, there was no significant improvement. In particular, 144 of 196 patients (73.5%) treated through an anterior approach and 114 of 223 (51.1%) that underwent a posterior approach, did not present a significant improvement. Furthermore, in 12.17% of patients, the postoperative outcome was not reported, leading to a high risk of bias in the assessment of the prognostic significance of the “snake-eyes” appearance; (4) Conclusions: The “snake-eyes” sign is usually considered as an unfavorable predictive marker for myelopathic surgical patients, but the pathophysiology is still unclear, and the results have not yet reached unified levels of evidence.
Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology
Tillema, Jan‐Mendelt , Guo, Yong , Weigand, Stephen D. , Metz, Imke , Brück, Wolfgang , Giraldo‐Chica, Mónica , Lucchinetti, Claudia F. , Tobin, William Oliver, Metz, Imke , Lucchinetti, Claudia F , Kalinowska, Alicja , Tobin, W. Oliver , Lassmann, Hans , Port, John D.

Mayo Clinic

Annals of Clinical and Translational Neurology | February 10, 2023 | Volume: 10 | Issue: 3 | Pages: 339-352

10.1002/acn3.51723 | PMID 36759436 Get It

AbstractObjectiveIn this observational study on a cohort of biopsy‐proven central nervous system demyelinating disease consistent with MS, we examined the relationship between early‐active demyelinating lesion immunopattern (IP) with subsequent clinical course, radiographic progression, and cognitive function.MethodsSeventy‐five patients had at least one early‐active lesion on biopsy and were pathologically classified into three immunopatterns based on published criteria. The median time from biopsy at follow‐up was 11 years, median age at biopsy ‐ 41, EDSS ‐ 4.0. At last follow‐up, the median age was 50, EDSS ‐ 3.0. Clinical examination, cognitive assessment (CogState battery), and 3‐Tesla‐MRI (MPRAGE/FLAIR/T2/DIR/PSIR/DTI) were obtained.ResultsIP‐I was identified in 14/75 (19%), IP‐II was identified in 41/75 (56%), and IP‐III was identified in 18/75 (25%) patients. Patients did not differ significantly by immunopattern in clinical measures at onset or last follow‐up. The proportions of disease courses after a median of 11 years were similar across immunopatterns, relapsing–remitting being most common (63%), followed by monophasic (32%). No differences in volumetric or DTI measures were found. CogState performance was similar for most tasks. A slight yet statistically significant difference was identified for episodic memory scores, with IP‐III patients recalling one word less on average.InterpretationIn this study, immunopathological heterogeneity of early‐active MS lesions identified at biopsy does not correlate with different long‐term clinical, neuroimaging or cognitive outcomes. This could be explained by the fact that while active white matter lesions are pathological substrates for relapses, MS progression is driven by mechanisms converging across immunopatterns, regardless of pathogenic mechanisms driving the acute demyelinated plaque.
Clinical differences in symptomology, characteristics, and risk factors in patients with post-acute sequelae of COVID-19: an experience from a tertiary-care academic center
Munipalli, Bala, Mohabbat, Arya B. , Siddiqui, Habeeba, Li, Zhuo , Paul, Stefan , Mohabbat, Arya, Paul, Stefan, Dabrh, Abd Moain Abu

Mayo Clinic

Journal of Investigative Medicine | February 10, 2023 | Volume: 71 | Issue: 5 | Pages: 495-501

10.1177/10815589231153604 | PMID 36760093 Get It

Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus SARS-CoV-2 and has caused significant mortality and morbidity since it was first recognized in Wuhan, China in December 2019. Patients may suffer from a constellation of symptoms termed post-acute sequelae of COVID-19 (PASC) . Here we present findings of a retrospective cohort study describing the prevalence and predicting factors of patient-reported post-acute sequelae of COVID-19 (PASC). Categorical variables were summarized as frequency (percentage) and compared between vaccine status groups using Fisher’s exact test. Continuous variables were reported as median (range) and compared between the groups using Kruskal-Wallis test. All tests were two-sided with p value <0.05 considered statistically significant. Survey data from 132 patients with a median age of 45 years, 68% female, 83% Caucasian/Non-Hispanic. The most frequently reported PASC symptoms include fatigue (84.8%), dyspnea (54.5%), cognitive dysfunction (53%), myalgias (37.1%), lightheadedness or vertigo (36.4%), chest pain (34.8%), palpitations (34.8%), headaches (34.1%), arthralgias (31.8%), and unrefreshing sleep (31.1%). There is mounting evidence that supports higher prevalence of PASC in women, White/Caucasian, and middle-aged individuals. This knowledge can provide guidance to clinical practices to anticipate and support healthcare and self-care needs for patients at higher risk to developing PASC.